MYLAN 357 (Pentoxifylline 400 mg)
Pill imprint MYLAN 357 has been identified as Pentoxifylline 400 mg.
Pentoxifylline is used in the treatment of intermittent claudication and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Pentoxifylline 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- MYLAN 357
- 400 mg
- 16.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Miscellaneous coagulation modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- D&C Red No. 30
FD&C Blue No. 2
FD&C Yellow No. 6
hydroxyethyl cellulose (140 mpa.s at 5%)
|NDC Code||Manufacturer / Repackager|
|51079-0889||UDL Laboratories Inc|
Note: Inactive ingredients may vary.
More about pentoxifylline
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.